Electronic records and electronic signatures in FDA-regulated work.
Part 11 sets the conditions under which FDA accepts electronic records and signatures as equivalent to paper. It requires validated systems, secure and computer-generated audit trails, authority checks, and signatures linked to their records. It applies to pharma, biotech, medical devices, food, and clinical research.
These controls exist because the platform needs them to run safely. The crosswalk reads their signed evidence against 21 CFR Part 11. Where there is no evidence, the report says gap.